Syndication: The Topeka Capital-Journal
New York (77WABC) – A new report from Pfizer says that a third dose of their Pfizer/BioNTech COVID-19 vaccine can “strongly” boost protection against the Delta variant much more than the protection afforded by the standard two doses.
The data suggests that antibody levels against the Delta variant in people ages 18 to 55 who receive a third dose of vaccine, are greater than five-fold than following a second dose. It also suggests that for people ages 65 to 85, antibody levels against the Delta variant after receiving a third dose of vaccine are greater than 11-fold than after a second shot.
There’s “estimated potential for up to 100-fold increase in Delta neutralization post-dose three compared to pre-dose three,” researchers wrote in the report.
The data also show that antibody levels are much higher after a third dose than a second dose against the original coronavirus variant and the Beta variant, which was first found in South Africa.
The data have not yet been peer-reviewed or published.
